Summary
The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.
The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.
The public comment period ends on May 7, after which the FDA may finalize the ban.
I’ve gotten into the habit of checking active ingredients after almost accidentally buying something homeopathic that was immediately adjacent the thing I actually meant to grab.